Ekso Bionics Holdings, INC Schedule 13G passive stakes

Armistice Capital, LLC and Steven Boyd have reported a 4.99% stake in Ekso Bionics Holdings, Inc. as of March 31, 2026.

Mink Brook Partners LP and affiliated entities have filed a Schedule 13G, reporting no beneficial ownership of ChronoScale Corp common stock as of May 14, 2026.

Mink Brook Partners LP, along with affiliated entities and William Mueller, has reported beneficial ownership of 190,596 shares, representing 5.4% of Ekso Bionics Holdings, Inc. common stock.

Daniel Asher and affiliated entities increased their beneficial ownership in Ekso Bionics Holdings, Inc. to 16.51% following a preferred share conversion.

Daniel Asher and DBA Trading, LLC have reported a significant passive stake in Ekso Bionics Holdings, Inc., acquiring additional shares in late December.

Armistice Capital, LLC and Steven Boyd reported beneficial ownership of 9.99% of Ekso Bionics Holdings, Inc. common stock as of June 30, 2025.

Investment firm Armistice Capital, LLC and Steven Boyd have reported a beneficial ownership of 9.99% in Ekso Bionics Holdings, Inc., holding 2,996,732 shares of common stock.

Armistice Capital, LLC and Steven Boyd have filed an amended Schedule 13G, reporting a beneficial ownership of 9.99% in Ekso Bionics Holdings, Inc. as of December 31, 2024.

Kent Lake PR LLC, Kent Lake Partners LP, and Benjamin Natter have jointly disclosed a passive beneficial ownership of 4.6% in Ekso Bionics Holdings, Inc., holding 1,000,000 shares of common stock.